Literature DB >> 5025038

Ultrastructural observations in Guillain-Barre syndrome.

M N Hart, D T Hanks, R Mackay.   

Abstract

Entities:  

Mesh:

Year:  1972        PMID: 5025038

Source DB:  PubMed          Journal:  Arch Pathol        ISSN: 0363-0153


× No keyword cloud information.
  8 in total

1.  A fulminant case of Guillain-Barré syndrome: topographic and fibre size related analysis of demyelinating changes.

Authors:  T Kanda; H Hayashi; H Tanabe; T Tsubaki; M Oda
Journal:  J Neurol Neurosurg Psychiatry       Date:  1989-07       Impact factor: 10.154

2.  Hypertrophic neuropathy in a dog.

Authors:  J F Cummings; A de Lahunta
Journal:  Acta Neuropathol       Date:  1974       Impact factor: 17.088

3.  Chronic relapsing polyradiculoneuritis in a dog. A clinical, light- and electron-microscopic study.

Authors:  J F Cummings; A de Lahunta
Journal:  Acta Neuropathol       Date:  1974       Impact factor: 17.088

4.  Antigen-specific demyelination and significance of the bystander effect in peripheral nerves.

Authors:  H C Powell; S L Braheny; R A Hughes; P W Lampert
Journal:  Am J Pathol       Date:  1984-03       Impact factor: 4.307

5.  Coonhound paralysis. Further clinical studies and electron microscopic observations.

Authors:  J F Cummings; A de Lahunta; D F Holmes; R D Schultz
Journal:  Acta Neuropathol       Date:  1982       Impact factor: 17.088

6.  Neuritis of the cauda equina, a chronic idiopathic polyradiculoneuritis in the horse.

Authors:  J F Cummings; A de Lahunta; J F Timoney
Journal:  Acta Neuropathol       Date:  1979-04-12       Impact factor: 17.088

Review 7.  Cerebrospinal fluid biomarkers in Guillain-Barré syndrome--where do we stand?

Authors:  Johannes Brettschneider; Axel Petzold; Sigurd Süssmuth; Hayrettin Tumani
Journal:  J Neurol       Date:  2009-02-16       Impact factor: 4.849

Review 8.  Guillain-Barré syndrome: clinical and immunological aspects.

Authors:  A M Rostami
Journal:  Springer Semin Immunopathol       Date:  1995
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.